Laura Agate

Pisa, 56124, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 58 publications

Molecular Profile of Advanced Radioiodine-refractory Thyroid Cancer and Response to Lenvatinib Treatment.

Molecular Profile of Advanced Radioiodine-refractory Thyroid Cancer and Response to Lenvatinib Treatment.

Journal: The Journal of clinical endocrinology and metabolism

Published: October 14, 2025

Redefining the prevalence of different clinical variants in MEN2A and their correlation with RET germline mutations: a single-center series and experience.

Redefining the prevalence of different clinical variants in MEN2A and their correlation with RET germline mutations: a single-center series and experience.

Journal: Endocrine-related cancer

Published: July 04, 2025

Long-Term Outcome of Patients with Low-Risk Differentiated Thyroid Cancer Treated with Total Thyroidectomy Alone.

Long-Term Outcome of Patients with Low-Risk Differentiated Thyroid Cancer Treated with Total Thyroidectomy Alone.

Journal: Current oncology (Toronto, Ont.)

Published: August 01, 2024

Hand-foot syndrome in sorafenib and lenvatinib treatment for advanced thyroid cancer.

Hand-foot syndrome in sorafenib and lenvatinib treatment for advanced thyroid cancer.

Journal: European thyroid journal

Published: January 09, 2024

Significance of Thyroglobulin Autoantibodies in Patients With Thyroid Cancer Treated With Lenvatinib.

Significance of Thyroglobulin Autoantibodies in Patients With Thyroid Cancer Treated With Lenvatinib.

Journal: Journal of the Endocrine Society

Published: April 13, 2023

Thyroid autoimmunity, thyroglobulin autoantibodies, and thyroid cancer prognosis.

Thyroid autoimmunity, thyroglobulin autoantibodies, and thyroid cancer prognosis.

Journal: Endocrine-related cancer

Published: March 03, 2023

Enlargement of a metastatic lymph node from differentiated thyroid cancer after COVID-19 vaccination.

Enlargement of a metastatic lymph node from differentiated thyroid cancer after COVID-19 vaccination.

Journal: Endocrine

Published: March 02, 2023

Radio-iodine refractory thyroid cancer patients: a tailored follow-up based on clinicopathological features.

Radio-iodine refractory thyroid cancer patients: a tailored follow-up based on clinicopathological features.

Journal: Journal of endocrinological investigation

Published: January 11, 2023

Active surveillance in differentiated thyroid cancer: a strategy applicable to all treatment categories response.

Active surveillance in differentiated thyroid cancer: a strategy applicable to all treatment categories response.

Journal: Frontiers in endocrinology

Published: December 29, 2022

Clinical Evolution of Sporadic Medullary Thyroid Carcinoma With Biochemical Incomplete Response After Initial Treatment.

Clinical Evolution of Sporadic Medullary Thyroid Carcinoma With Biochemical Incomplete Response After Initial Treatment.

Journal: The Journal of clinical endocrinology and metabolism

Published: November 28, 2022

Pros and cons of an aggressive initial treatment with surgery and radioiodine treatment in minimally invasive follicular thyroid carcinoma.

Pros and cons of an aggressive initial treatment with surgery and radioiodine treatment in minimally invasive follicular thyroid carcinoma.

Journal: Thyroid research

Published: October 07, 2022

Yttrium-90 transarterial radioembolization for liver metastases from medullary thyroid cancer.

Yttrium-90 transarterial radioembolization for liver metastases from medullary thyroid cancer.

Journal: European thyroid journal

Published: September 16, 2022

Showing 1-12 of 58

Last Updated: 09/26/2026